Immunotherapy of cancer with alloreactive lymphocytes
- 1 August 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (8) , 491-498
- https://doi.org/10.1016/s1470-2045(01)00455-7
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Mini-allografts: ongoing trials in humansBone Marrow Transplantation, 2000
- T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapseBritish Journal of Haematology, 1995
- Generation of Donor-Derived Antileukemic Cytotoxic T-Lymphocyte Responses for Treatment of Relapsed Leukemia After Allogeneic HLA-Identical Bone Marrow TransplantationJournal of Immunotherapy, 1993
- Use of Recombinant Human Interleukin-2 in Conjunction with Bone Marrow Transplantation as a Model for Control of Minimal Residual Disease in Malignant Hematological Disorders: I. Treatment of Murine Leukemia in Conjunction with Allogeneic Bone Marrow Transplantation and IL-2-Activated Cell-Mediated ImmunotherapyCancer Investigation, 1992
- New developments in bone marrow transplantationCurrent Opinion in Oncology, 1991
- Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemiaCancer Immunology, Immunotherapy, 1990
- Total lymphoid irradiationImmunology Today, 1987
- POSSIBILITY OF GRAFT-VS-LEUKEMIA DETERMINANTS INDEPENDENT OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN ALLOGENEIC MARROW TRANSPLANTATIONTransplantation, 1983
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation.The Journal of Experimental Medicine, 1978